Heart & Stroke 2024 risk assessment tool – EN
Read Heart & Stroke 2024 risk assessment tool – EN by heartandstroke on Issuu and browse thousands of other publications on our platform. Start here!
Read Heart & Stroke 2024 risk assessment tool – EN by heartandstroke on Issuu and browse thousands of other publications on our platform. Start here!
It is with great sadness but also with honor we write in memory of our dear friend and colleague David E. Haines, MD. David passed…
BackgroundWe examined the association between hemoglobin A1c (HbA1c) and the development of cardiovascular disease (CVD) in men and women, without diabetes or CVD at baseline.Methods…
In this week’s View, Dr. Eagle looks at the new AHA/ACC Hypertrophic Cardiomyopathy Guideline, then examines a randomized clinical trial that studied smoking cessation after…
Also, several new recommendations in update address younger patients
BACKGROUND: Stroke survivors face physical and cognitive challenges, leading to an increased dependency and a higher fall risk. We aimed to investigate the impact of…
The motion relationship and time intervals of the pulsed-wave Doppler (PWD) spectrum are essential for diagnosing fetal arrhythmia. However, few technologies currently are available to…
The newest clinical guideline, released May 8 by the ACC and the American Heart Association (AHA), provides the latest evidence-based recommendations for effectively managing individuals…
The renin-angiotensin system is the most important peptide hormone system in the regulation of cardiovascular homeostasis. Its classical arm consists of the enzymes, renin, and…
Ischemic stroke lesion volume at follow-up is an important surrogate outcome in acute stroke trials. Multiple issues outside of the stroke itself (aspiration pneumonia, pulmonary…
BackgroundPeriodic repolarization dynamics (PRD) is an electrocardiographic biomarker that captures repolarization instability in the low frequency spectrum and is believed to estimate the sympathe…